📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The why and how of adaptive immune responses in ischemic cardiovascular disease (2022)

First Author: Mallat Z

Attributed to: Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44161-022-00049-1

PubMed Identifier: 36382200

Publication URI: http://europepmc.org/abstract/MED/36382200

Type: Journal Article/Review

Parent Publication: Nature Cardiovascular Research

Issue: 5

ISSN: 2731-0590